Witnessing the stock’s movement on the chart, on Wednesday, Applied Dna Sciences Inc (NASDAQ: APDN) had a quiet start as it plunged -1.34% to $0.15, before settling in for the price of $0.16 at the close. Taking a more long-term approach, APDN posted a 52-week range of $0.15-$22.80.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 94.52%. Meanwhile, its Annual Earning per share during the time was 45.52%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 71.32%. This publicly-traded company’s shares outstanding now amounts to $50.90 million, simultaneously with a float of $50.83 million. The organization now has a market capitalization sitting at $7.77 million. At the time of writing, stock’s 50-day Moving Average stood at $0.3769, while the 200-day Moving Average is $3.0968.
Applied Dna Sciences Inc (APDN) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Diagnostics & Research industry. Applied Dna Sciences Inc’s current insider ownership accounts for 0.14%, in contrast to 2.12% institutional ownership.
Applied Dna Sciences Inc (APDN) Earnings and Revenue Records
Applied Dna Sciences Inc’s EPS increase for this current 12-month fiscal period is 71.32% and is forecasted to reach -1.04 in the upcoming year.
Applied Dna Sciences Inc (NASDAQ: APDN) Trading Performance Indicators
Let’s observe the current performance indicators for Applied Dna Sciences Inc (APDN). It’s Quick Ratio in the last reported quarter now stands at 3.76. The Stock has managed to achieve an average true range (ATR) of 0.03. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 2.29.
In the same vein, APDN’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -11.94, a figure that is expected to reach -0.34 in the next quarter, and analysts are predicting that it will be -1.04 at the market close of one year from today.
Technical Analysis of Applied Dna Sciences Inc (APDN)
Going through the that latest performance of [Applied Dna Sciences Inc, APDN]. Its last 5-days volume of 2.64 million was inferior to the volume of 3.72 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 30.58% While, its Average True Range was 0.0183.
Raw Stochastic average of Applied Dna Sciences Inc (APDN) in the period of the previous 100 days is set at 0.26%, which indicates a major fall in contrast to 18.59% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 43.89% that was lower than 252.22% volatility it exhibited in the past 100-days period.